Dermatan
R. Christopher Harmon · xPharm: The Comprehensive Pharmacology Reference · 2007
Cited by 0 works. doi:10.1016/b978-008055232-3.61561-2
Authors
References
- Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer
- The Absorption, Clearance and Metabolic Fate of Dermatan Sulphate Administered to Man - Studies Using a Radioiodinated Derivative
- The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.
- A Dose Ranging Study to Evaluate Dermatan Sulphate in Preventing Deep Vein Thrombosis following Total Hip Arthroplasty
- The Pharmacokinetics of LMW Dermatan Sulphate: Long-Term Persistence of Intact Material
- Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes
- Clinical experience with a new antithrombotic (dermatan sulfate) in chronic hemodialysis patients.
- A survey of the clinical experience with dermatan sulfate.
- Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
- Low molecular weight dermatan sulphate (Desmin 370) does not cross the ovine placenta